Acute vulvovaginitis.
Shirley RL.
N Engl J Med. 2006 Dec 28;355(26):2791; author reply 2791. doi: 10.1056/NEJMc062854.
Probiotics.
Williams NT.
Am J Health Syst Pharm. 2010 Mar 15;67(6):449-58. doi: 10.2146/ajhp090168.
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W.
Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.
Candidiasis (vulvovaginal).
Martin Lopez JE.
BMJ Clin Evid. 2015 Mar 16;2015:0815.
Clinical practice. Acute vulvovaginitis.
Eckert LO.
N Engl J Med. 2006 Sep 21;355(12):1244-52. doi: 10.1056/NEJMcp053720.
Urinary retention in adults: diagnosis and initial management.
Selius BA, Subedi R.
Am Fam Physician. 2008 Mar 1;77(5):643-50.
Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Martens MG, Maximos B, Degenhardt T, Person K, Curelop S, Ghannoum M, Flynt A, Brand SR.
Am J Obstet Gynecol. 2022 Dec;227(6):880.e1-880.e11. doi: 10.1016/j.ajog.2022.07.023. Epub 2022 Jul 19.
Fanconi Anemia.
Mehta PA, Ebens C.
2002 Feb 14 [updated 2021 Jun 3]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Dysuria: Evaluation and Differential Diagnosis in Adults.
Michels TC, Sands JE.
Am Fam Physician. 2015 Nov 1;92(9):778-86.
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
MacAlpine J, Lionakis MS.
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
